Catégorie - Pfizer
Pfizer shareholders to get vote on executive pay
Drugmaker Pfizer Inc. said Thursday its shareholders will have input on compensation for company executives starting in 2010. Shareholders will have a nonbinding advisory vote on executive compensation every two years, Pfizer said, meaning they can ratify or... Sponsored Topics: Executive compensation - Business - United States - Law - Workers' Compensation
2009-10-30 -
San Francisco Chronicle
Press Release
NEW YORK(BUSINESS WIRE)Pfizer (NYSE: PFE) and Wyeth (NYSE: WYE) announced today that Pfizer has completed its acquisition of Wyeth following the receipt of regulatory approval from all government authorities required by the merger agreement and approval by Wyeth shareholders.
2009-11-16 -
PharmiWeb
Pfizer submits new paediatric data for Lipitor to EMEA
Pfizer Inc has submitted paediatric data for Lipitor (atorvastatin) to the European Medicines Agency (EMEA). Pfizer has also developed a new chewable form of Lipitor, including a paediatric-appropriate 5 mg dose, which is part of this submission.
2009-11-20 -
PharmaBiz
Pfizer Dodges a Bullet
In order to gain approval, Wyeth tested the new vaccine against the old version, but Prevnar 13 failed to show that it was as good as the original for three ...
2009-11-19 -
Motley Fool
Pfizer to pay $8.8m to patient
LOS ANGELES - A PHILADELPHIA jury on Friday ordered pharmaceutical giant Pfizer to pay US$6.3 million (S$8.8 million) in compensatory damages to an Illinois breast cancer survivor after finding menopause drugs Premarin, Provera and Prempro caused the disease. The panel also found that punitive damages are warranted because of willful and wanton conduct by Pfizer units Wyeth and Pharmacia ...
2009-11-21 -
Straits Times
Pfizer to present study findings from its expanded breast cancer portfolio
Pfizer Oncology announced today that it will be presenting study findings evaluating several compounds including those from its newly expanded breast cancer portfolio following the recent acquisition of Wyeth, focusing on the needs of multiple breast cancer patient populations at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) being held December 9 – 13.
2009-12-04 -
News-Medical-Net
Pfizer announces a $9M cancer research collaboration in British Columbia
Pfizer is entering into a three-year, $9-million research collaboration with the BC Cancer Agency and the Vancouver Prostate Centre, a University of British Columbia (UBC) and Vancouver General Hospital (VGH) Centre of Excellence, to tackle new treatment avenues for breast, ovarian and prostate cancer. This is the single-largest investment by Pfizer into British Columbia's public research sector ...
2009-12-04 -
News-Medical-Net